Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Ove Törring"'
Autor:
Gabriel Sjölin, Torquil Watt, Kristina Byström, Jan Calissendorff, Per Karkov Cramon, Helena Filipsson Nyström, Bengt Hallengren, Mats Holmberg, Selwan Khamisi, Mikael Lantz, Tereza Planck, Ove Törring, Göran Wallin
Publikováno v:
Thyroid Research, Vol 15, Iss 1, Pp 1-8 (2022)
Abstract Background The purpose of treating toxic nodular goitre (TNG) is to reverse hyperthyroidism, prevent recurrent disease, relieve symptoms and preserve thyroid function. Treatment efficacies and long-term outcomes of antithyroid drugs (ATD), r
Externí odkaz:
https://doaj.org/article/b9c477d842054305a064caff699eca08
Autor:
Gabriel Sjölin, Kristina Byström, Mats Holmberg, Ove Törring, Selwan Khamisi, Jan Calissendorff, Mikael Lantz, Bengt Hallengren, Helena Filipsson Nyström, Tereza Planck, Göran Wallin
Publikováno v:
Endocrinology, Diabetes & Metabolism, Vol 4, Iss 3, Pp n/a-n/a (2021)
Abstract Introduction The treatment strategies for a 42‐year‐old female index patient with moderate Graves’ disease (GD) vary according to several international surveys. The important question whether surveys of treatment preferences in theoret
Externí odkaz:
https://doaj.org/article/b6837277c9194de99f946e3cc379d451
Publikováno v:
Endocrine.
Diclofenac is commonly used as pain relief. Hypoglycemia has rarely been reported due to aspirin and indomethacin use but not of any other nonsteroidal anti-inflammatory drugs.A 69-years old endocrinologist participated as a control in a glucagon-lik
Publikováno v:
Journal of the Endocrine Society
Gene variants of CYP24A1, which encodes the enzyme 24-hydroxylase, are a most unusual cause of maternal hypercalcemia. Loss-of-function mutations in CYP24A1 result in impaired dehydroxylation of active vitamin D (calcitriol). Secondary to this hyperc
Autor:
Steven R, Cummings, Serge, Ferrari, Richard, Eastell, Nigel, Gilchrist, Jens-Erik Beck, Jensen, Michael, McClung, Christian, Roux, Ove, Törring, Ivo, Valter, Andrea T, Wang, Jacques P, Brown
Publikováno v:
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 33(2)
Denosumab reduces bone resorption and vertebral and nonvertebral fracture risk. Denosumab discontinuation increases bone turnover markers 3 months after a scheduled dose is omitted, reaching above-baseline levels by 6 months, and decreases bone miner
Autor:
Mirna Abraham-Nordling, Göran Wallin, Frank Träisk, Gertrud Berg, Jan Calissendorff, Bengt Hallengren, Pavo Hedner, Mikael Lantz, Ernst Nyström, Peter Åsman, Göran Lundell, Ove Törring
Publikováno v:
European Journal of Endocrinology. 163:651-657
ObjectiveThe objective of this study was to investigate quality of life (QoL) in patients with Graves' disease treated with radioiodine or antithyroid drugs.Design and methodsThe design of the study consists of an open, prospective, randomized multic
Autor:
Frank, Träisk, Leif, Tallstedt, Mirna, Abraham-Nordling, Tommy, Andersson, Gertrud, Berg, Jan, Calissendorff, Bengt, Hallengren, Pavo, Hedner, Mikael, Lantz, Ernst, Nyström, Vesna, Ponjavic, Adam, Taube, Ove, Törring, Göran, Wallin, Peter, Asman, Göran, Lundell, H, Blomgren
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 94:3700-3707
Previous randomized trials have suggested an association between radioiodine treatment for Graves' hyperthyroidism and thyroid-associated ophthalmopathy (TAO).The aim of the study was to compare the occurrence of worsening or development of TAO in pa
Publikováno v:
Lakartidningen. 112
Intoxication with vitamin D may lead to severe hypercalcemia, renal failure and occasionally to death. An increasing amount of vitamin D supplement is sold over-the-counter (OTC) or over the internet. Here we present a case were a person obtained vit
Autor:
Ove, Törring
Publikováno v:
Lakartidningen. 107(9)
Autor:
Mirna Abraham-Nordling, Ove Törring, Bertil Hamberger, Göran Lundell, Leif Tallstedt, Jan Calissendorff, Göran Wallin
Publikováno v:
Thyroid; Nov2005, Vol. 15 Issue 11, p1279-1286, 8p